Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review

Journal of Diabetes and its Complications

Volumn 30, Issue 5, 2016, Pages 958-966

  Wotherspoon, Amy C ^a   Young, Ian S ^a   McCance, David R ^b   Holmes, Valerie A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Pre eclampsia; Prediction; Systematic review; Type 1 diabetes

Indexed keywords

ACTIVIN A; ANGIOGENIC FACTOR; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CAROTENOID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INHIBIN A; INTERCELLULAR ADHESION MOLECULE 1; OROSOMUCOID; PENTRAXIN 3; PRORENIN; RENIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

CHOLESTEROL BLOOD LEVEL; CINAHL; EMBASE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL RECORD; MEDLINE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; SCOPUS; SYSTEMATIC REVIEW; WEB OF SCIENCE; BLOOD; COMPLICATION; EARLY DIAGNOSIS; FEMALE; HIGH RISK PREGNANCY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL DIAGNOSIS; TRENDS; URINE;

BIOMARKERS; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; EARLY DIAGNOSIS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS;

EID: 84958580964     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.02.001     Document Type: Review

References (68)

1. R. Akolekar, J. de Cruz, J. Foidart, C. Munaut, and K.H. Nicolaides Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia Prenatal Diagnosis 30 3 2010 191 197
2. R. Akolekar, R. Minekawa, A. Veduta, X.C. Romero, and K.H. Nicolaides Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy Prenatal Diagnosis 29 8 2009 753 760
3. R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, and K.H. Nicolaides Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia Prenatal Diagnosis 29 12 2009 1103 1108
4. R. Akolekar, A. Syngelaki, L. Poon, D. Wright, and K.H. Nicolaides Competing risks model in early screening for preeclampsia by biophysical and biochemical markers Fetal Diagnosis and Therapy 33 1 2012 8 15
5. R. Akolekar, A. Syngelaki, R. Sarquis, M. Zvanca, and K.H. Nicolaides Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks Prenatal Diagnosis 31 1 2011 66 74
6. R. Akolekar, E. Zaragoza, L. Poon, S. Pepes, and K. Nicolaides Maternal serum placental growth factor at 11 0 to 13 6 weeks of gestation in the prediction of pre-eclampsia Ultrasound in Obstetrics & Gynecology 32 6 2008 732 739
7. M. Azar, A. Basu, A.J. Jenkins, A.J. Nankervis, K.F. Hanssen, and H. Scholz T.J. Lyons Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: A longitudinal study Diabetes Care 34 6 2011 1258 1264
8. A.A. Baschat, L.S. Magder, L.E. Doyle, R.O. Atlas, C.B. Jenkins, and M.G. Blitzer Prediction of preeclampsia utilizing the first trimester screening examination Obstetrics and Gynecology 211 5 2014 (514. e1-514. e7)
9. A. Basu, P. Alaupovic, M. Wu, A.J. Jenkins, Y. Yu, and A.J. Nankervis T.J. Lyons Plasma lipoproteins and preeclampsia in women with type 1 diabetes: A prospective study The Journal of Clinical Endocrinology and Metabolism 97 5 2012 1752 1762
10. M.U. Baumann, N.A. Bersinger, M.G. Mohaupt, L. Raio, S. Gerber, and D.V. Surbek First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia Obstetrics and Gynecology 199 3 2008 266.e1 266.e6
11. S. Baweja, A. Kent, R. Masterson, S. Roberts, and L. McMahon Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: Creatinine ratio using high-performance liquid chromatography BJOG: An International Journal of Obstetrics & Gynaecology 118 9 2011 1126 1132
12. P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, and L.M. Irwig J.G. Lijmer Standards for Reporting of Diagnostic Accuracy Group. The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration Annals of Internal Medicine 138 1 2003 W1 W12
13. M.A. Brown, M.D. Lindheimer, M. de Swiet, A.V. Assche, and J. Moutquin The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertension in Pregnancy 20 1 2001 ix xiv
14. D.M. Carty, J. Siwy, J.E. Brennand, P. Zurbig, W. Mullen, J. Franke, and C. Delles C. Delles Urinary proteomics for prediction of preeclampsia Hypertension 57 3 2011 561 569
15. M.T. Castiglioni, M. Scavini, R. Cavallin, F. Pasi, S. Rosa, and M.G. Sabbadini P. Rovere-Querini Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes Autoimmunity 42 4 2009 296 298
16. M.S. Christiansen, D. Hesse, P. Ekbom, U. Hesse, P. Damm, and E. Hommel E. Mathiesen Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes Diabetes Research and Clinical Practice 89 1 2010 16 21
17. P. Clausen, P. Ekbom, P. Damm, U. Feldt-Rasmussen, B. Nielsen, and E.R. Mathiesen B. Feldt-Rasmussen Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes Journal of Diabetes and its Complications 21 5 2007 288 293
18. C.A. Combs, B. Rosenn, J.L. Kitzmiller, J.C. Khoury, and B.C. Wheeler M. Miodovnik Early-pregnancy proteinuria in diabetes related to preeclampsia Obstetrics and Gynecology 82 5 1993 802 807
19. B.F. Crandall, L. Robinson, and P. Grau Risks associated with an elevated maternal serum alpha-fetoprotein level American Journal of Obstetrics & Gynecology 165 3 1991 581 586
20. F. Crispi, E. Llurba, C. Dominguez, P. Martín-Gallán, L. Cabero, and E. Gratacos Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction Ultrasound in Obstetrics & Gynecology 31 3 2008 303 309
21. P. Damm, H. Mersebach, J. Råstam, R. Kaaja, M. Hod, and D.R. McCance E.R. Mathiesen Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester The Journal of Maternal-Fetal & Neonatal Medicine 27 2 2013 149 154
22. L. Dawonauth, L. Rademacher, A.D. L'Omelette, S. Jankee, M.Y. Lee Kwai Yan, and R.B. Jeeawoody T.W. Rademacher Urinary inositol phosphoglycan-P type: Near patient test to detect preeclampsia prior to clinical onset of the disease. A study on 416 pregnant Mauritian women Journal of Reproductive Immunology 101 2014 148 152
23. M. Du, A. Basu, D. Fu, M. Wu, M. Centola, and A.J. Jenkins T.J. Lyons Serum inflammatory markers and preeclampsia in type 1 diabetes: A prospective study Diabetes Care 36 7 2013 2054 2061
24. L. Duley, D. Henderson-Smart, S. Meher, and J. King Antiplatelet agents for preventing pre-eclampsia and its complications Cochrane Database of Systematic Reviews 2 2007
25. P. Ekbom Pre-pregnancy microalbuminuria predicts pre-eclampsia in insulin-dependent diabetes mellitus. Copenhagen Pre-eclampsia in Diabetic Pregnancy Study Group Lancet 353 9150 1999 377
26. P. Ekbom, P. Damm, A.M. Andersson, N.E. Skakkebaek, U. Feldt-Rasmussen, and E.R. Mathiesen Serum levels of activin A and inhibin A are not related to the increased susceptibility to pre-eclampsia in type I diabetic pregnancies Acta Obstetricia et Gynecologica Scandinavica 85 2 2006 143 147
27. P. Ekbom, P. Damm, K. Nogaard, P. Clausen, U. Feldt-Rasmussen, and B. Feldt-Rasmussen E.R. Mathiesen Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in type I diabetes Diabetologia 43 7 2000 927 931
28. P.R. Garner, M.E. D'Alton, D.K. Dudley, P. Huard, and M. Hardie Preeclampsia in diabetic pregnancies Obstetrics and Gynecology 163 2 1990 505 508
29. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: preeclampsia Obstetrics and Gynecology 202 2010 (255 e1-255 e7)
30. V. Hiilesmaa, L. Suhonen, and K. Teramo Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with Type I diabetes mellitus Diabetologia 43 12 2000 1534 1539
31. V.A. Holmes, I.S. Young, C.C. Patterson, M.J. Maresh, D.W. Pearson, and J.D. Walker McCance DR; Diabetes and Preeclampsia Intervention Trial (DAPIT) Study Group The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes Diabetes Care 36 11 2013 3671 3677
32. V.A. Holmes, I.S. Young, C.C. Patterson, D.W. Pearson, J.D. Walker, and M.J. Maresh McCance DR; Diabetes and Preeclampsia Intervention Trial (DAPIT) Study Group Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial Diabetes Care 34 8 2011 1683 1688
33. C.D. Hsu, S.F. Hong, N.A. Nickless, and J.A. Copel Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia American Journal of Perinatology 15 3 1998 199 202
34. D.M. Jensen, P. Damm, P. Ovesen, L. Mølsted-Pedersen, H. Beck-Nielsen, and J.G. Westergaard E.R. Mathiesen Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: Results from a nationwide Danish study Diabetes Care 33 1 2010 90 94
35. L.C. Kenny, D.I. Broadhurst, W. Dunn, M. Brown, R.A. North, and L. McCowan Baker P.N.; Screening for Pregnancy Endpoints Consortium Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers Hypertension 56 4 2010 741 749
36. A. Khalil, N.J. Cowans, K. Spencer, S. Goichman, H. Meiri, and K. Harrington First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk Prenatal Diagnosis 29 8 2009 781 789
37. F.F. Lauszus, O.W. Rasmussen, T. Lousen, T.M. Klebe, and J.G. Klebe Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation Acta Obstetricia et Gynecologica Scandinavica 80 12 2001 1096 1103
38. T.F. McElrath, K. Lim, E. Pare, J. Rich-Edwards, D. Pucci, and R. Troisi S. Parry Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy Obstetrics and Gynecology 207 5 2012 (407. e1-407. e7)
39. T.D. Metz, A.A. Allshouse, A.G. Euser, and K.D. Heyborne Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers Obstetrics and Gynecology 211 5 2014 (512. e1-512. e6)
40. B. Mikat, A. Gellhaus, N. Wagner, C. Birdir, R. Kimmig, and A. Köninger Early detection of maternal risk for preeclampsia ISRN Obstetrics and Gynecology 2012 2012
41. J. Myers, L. Kenny, L. McCowan, E. Chan, G. Dekker, and L. Poston North R.A.; SCOPE consortium Angiogenic factors combined with clincial risk factors to predict preterm pre-eclampsia in nulliparous women: A predictive test accuracy study BJOG: An International Journal of Obstetrics & Gynaecology 120 10 2013 1215 1223
42. K.H. Nicolaides A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment Prenatal Diagnosis 31 1 2011 3 6
43. R.A. North, L.M. McCowan, G.A. Dekker, L. Poston, E.H. Chan, and A.W. Stewart L.C. Kenny Clinical risk prediction for pre-eclampsia in nulliparous women: Development of model in international prospective cohort BMJ [British Medical Journal] 342 2011
44. M. Odeh, E. Ophir, O. Maximovsky, V. Grinin, and J. Bornstein Placental volume and three-dimensional power Doppler analysis in prediction of pre-eclampsia and small for gestational age between week 11 and 13 weeks and 6 days of gestation Prenatal Diagnosis 31 4 2011 367 371
45. E. Parretti, A. Lapolla, M. Dalfra, G. Pacini, A. Mari, and R. Cioni G. Mello Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes Hypertension 47 3 2006 449 453
46. M. Persson, M. Norman, and U. Hanson Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study Diabetes Care 32 11 2009 2005 2009
47. L. Poon, N. Maiz, C. Valencia, W. Plasencia, and K. Nicolaides First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia Ultrasound in Obstetrics & Gynecology 33 1 2009 23 33
48. J. Rasanen, A. Girsen, X. Lu, J.A. Lapidus, M. Standley, and A. Reddy S.R. Nagalla Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia Journal of Proteome Research 9 8 2010 4274 4281
49. L. Ringholm, U. Pedersen-Bjergaard, B. Thorsteinsson, F. Boomsma, P. Damm, and E.R. Mathiesen A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes Diabetologia 54 7 2011 1615 1619
50. L. Ringholm, U. Pedersen-Bjergaard, B. Thorsteinsson, F. Boomsma, P. Damm, and E.R. Mathiesen Atrial natriuretic peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes Diabetes Research and Clinical Practice 93 3 2011 e106 e109
51. J.M. Roberts, and H.S. Gammill Preeclampsia: Recent insights Hypertension 46 6 2005 1243 1249
52. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia The Lancet 365 9461 2005 785 799
53. K. Spencer, N.J. Cowans, and K.H. Nicolaides Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia Prenatal Diagnosis 28 1 2008 7 10
54. K. Spencer, N. Cowans, and K. Nicolaides Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia Ultrasound in Obstetrics & Gynecology 32 5 2008 622 626
55. A.C. Staff, S.J. Benton, P. von Dadelszen, J.M. Roberts, R.N. Taylor, and R.W. Powers C.W. Redman Redefining preeclampsia using placenta-derived biomarkers Hypertension 61 5 2013 932 942
56. R.S. Starikov, K. Inman, E.K. Chien, B.L. Anderson, D.J. Rouse, and V. Lopes D.R. Coustan Can hemoglobin A1c in early pregnancy predict adverse pregnancy outcomes in diabetic patients? Journal of Diabetes and its Complications 28 2 2014 203 207
57. Y. Sun, H. Yang, and W.J. Sun Risk factors for pre-eclampsia in pregnant Chinese women with abnormal glucose metabolism International Journal of Gynecology & Obstetrics 101 1 2008 74 76
58. R.C. Temple, V. Aldridge, K. Stanley, and H.R. Murphy Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes BJOG: An International Journal of Obstetrics and Gynaecology 113 11 2006 1329 1332
59. R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, and V.P. Sukhatme S.A. Karumanchi First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia The Journal of Clinical Endocrinology & Metabolism 89 2 2004 770 775
60. T. Ulmannova, D. Bartaskova, I. Spalova, P. Zoban, Z. Vesely, and K. Stechova Maternal BMI and HDL as predictors of pregnancy outcome in women with type 1 diabetes The Journal of Maternal-Fetal & Neonatal Medicine 27 15 2014 1580 1583
61. F.A. Van Assche, B. Spitz, M. Hanssens, C. Van Geet, J. Arnout, and J. Vermylen Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia American Journal of Obstetrics & Gynecology 168 1 Pt 1 1993 84 87
62. T.L. Weissgerber, R.E. Gandley, J.M. Roberts, C.C. Patterson, V.A. Holmes, and I.S. Young McCance D.R; Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes BJOG: An International Journal of Obstetrics & Gynaecology 120 10 2013 1192 1199
63. P.F. Whiting, A.W. Rutjes, M.E. Westwood, S. Mallett, J.J. Deeks, and J.B. Reitsma Bossuyt PM; QUADAS-2 Group. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies Annals of Internal Medicine 155 8 2011 529 536
64. J. Wilson, and G. Jungner Principles and practice of screening for disease Public Health Pap 34 1968 WHO Geneva
65. A. Youssef, F. Righetti, D. Morano, N. Rizzo, and A. Farina Uterine artery Doppler and biochemical markers (PAPP-A, PlGF, sFlt-1, P-selectin, NGAL) at 11 0 to 13 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia Prenatal Diagnosis 31 12 2011 1141 1146
66. Y. Yu, K.F. Hanssen, V. Kalyanaraman, A. Chirindel, A.J. Jenkins, and A.J. Nankervis T.J. Lyons Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in type 1 diabetes BJOG: An International Journal of Obstetrics and Gynaecology 119 12 2012 1512 1520
67. Y. Yu, A.J. Jenkins, A.J. Nankervis, K.F. Hanssen, H. Scholz, and T. Henriksen T.J. Lyons Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women Diabetologia 52 1 2009 160 168
68. J. Zhou, L. Su, M. Liu, Y. Liu, X. Cao, and Z. Wang H. Xiao Associations between 25-hydroxyvitamin D levels and pregnancy outcomes: A prospective observational study in southern China European Journal of Clinical Nutrition 68 8 2014 925 930